Filtros de búsqueda

Lista de obras de Wolfram Samlowski

A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma

artículo científico publicado en 2009

A nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects

artículo científico publicado en 2003

A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma

artículo científico publicado en 2010

A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma

artículo científico publicado en 2014

A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)

artículo científico publicado en 2010

A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group Study

artículo científico publicado en 1999

Autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia and renal cell carcinoma after treatment with high-dose intravenous bolus interleukin-2

artículo científico publicado en 2000

Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology

artículo científico publicado en 2011

Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology

artículo científico publicado en 2012

Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells

scientific article published on 01 August 2000

Effects of Total Parenteral Nutrition (TPN) During High-Dose Interleukin-2 Treatment for Metastatic Cancer ⬇️

artículo científico publicado el 1 de enero de 1998

Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial

artículo científico publicado en 1995

Emerging drugs for the treatment of metastatic renal cancer.

artículo científico publicado en 2007

Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome

artículo científico publicado en 2011

Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation

artículo científico publicado en 2005

High frequency of brain metastases after adjuvant therapy for high-risk melanoma

artículo científico publicado en 2017

Image of the month. Hemoptysis in a patient with melanoma and pulmonary infiltrates

artículo científico publicado en 2008

Immunosuppressive effects of factor IX products: an in vitro study

artículo científico publicado en 1999

Increased Melanocytic Nevi and Nevus Density in a G-34T CDKN2A/p16 Melanoma-Prone Pedigree

scientific article published on 13 March 2008

Inducible nitric oxide synthase (iNOS) is not required for IL-2-induced hypotension and vascular leak syndrome in mice

artículo científico publicado en 2008

Long-term response in primary renal cancer to sequential antiangiogenic therapy

artículo científico publicado en 2009

Longitudinal assessment of the nevus phenotype in a melanoma kindred

artículo científico publicado en 2004

Management of metastatic melanoma patients with brain metastases.

artículo científico publicado en 2007

Management of renal cancer in the tyrosine kinase inhibitor era: a view from 3 years on.

artículo científico publicado en 2008

Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction

scientific article published on 01 October 2005

Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery

artículo científico publicado en 2008

Multimodality management of brain metastases in metastatic melanoma patients.

artículo científico publicado en 2007

Nitric oxide exposure inhibits induction of lymphokine-activated killer cells by inducing precursor apoptosis

artículo científico publicado en 1998

Phase 1 study of escalating-dose OncoGel (ReGel/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions

scientific article published on 01 March 2007

Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma ⬇️

artículo científico publicado el 19 de julio de 2011

Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: a Southwest Oncology Group study

artículo científico publicado en 1990

Primary treatment of verrucous carcinoma of the penis with fluorouracil, cis-diamino-dichloro-platinum, and radiation therapy

artículo científico publicado en 2009

Quantitative analysis of cytokine-induced vascular toxicity and vascular leak in the mouse brain

artículo científico publicado en 2009

Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study

artículo científico publicado en 2004

Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinoma.

artículo científico publicado en 2012

Receptor-Mediated Activation of Murine Peritoneal Macrophages by Antithrombin III Acts as a Costimulatory Signal for Nitric Oxide Synthesis ⬇️

artículo científico publicado el 25 de agosto de 1998

Relative importance of cytotoxic T lymphocytes and nitric oxide-dependent cytotoxicity in contractile dysfunction of rejecting murine cardiac allografts

artículo científico publicado en 1998

Suppression of cytokine-inducible nitric oxide synthesis during intraperitoneal Meth A tumor growth.

artículo científico publicado en 2004

Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy ⬇️

artículo científico publicado el 6 de junio de 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda